|
1.
|
|
7 p, 384.6 KB |
Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
/
Fernández-Bergés, Daniel (Instituto Universitario de Investigación Biosanitaria de Extremadura) ;
Degano, Irene R (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Gonzalez Fernandez, Reyes (Infanta Cristina University Hospital) ;
Subirana, Isaac (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Vila, Joan (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Jiménez-Navarro, Manuel (Virgen de la Victoria University Hospital) ;
Perez-Fernandez, Silvia (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Roqué, Mercé (Hospital Clinic) ;
Bayes-Genis, Antoni (Hospital Germans Trias i Pujol) ;
Fernandez-Aviles, Francisco (University Hospital Gregorio Marañon) ;
Mayorga, Antonio (Hospital Universitario Gregorio Marañón, Madrid) ;
Bertomeu-Gonzalez, Vicente (Hospital Universitario de San Juan) ;
Sanchis, Juan (Hospital Clinico Universitario, INCLIVA, Universitat de València) ;
Rodríguez Esteban, Marcos (Hospital Universitario Nuestra Senora de la Candelaria) ;
Sanchez-Hidalgo, Antonio (Consorci Sanitari de Terrassa) ;
Sanchez-Insa, Esther (Hospital Universitario Miguel Servet) ;
Elorriaga, Ane (Hospital Universitario de Basurto, Bilbao) ;
Abu Assi, Emad (Hospital Álvaro Junqueiro de Vigo, Pontevedra) ;
Nuñez, Alberto (Hospital Universitario Fundación de Alcorcón) ;
Garcia Ruiz, Jose Manuel (Hospital Universitario Central de Asturias) ;
Morrondo Valdeolmillos, Pedro (Hospital Universitario Donostia, San Sebastián) ;
Bosch-Portell, Daniel (Hospital Universitari de Girona Doctor Josep Trueta) ;
Lekuona, Iñaki (Hospital Galdakao-Usansolo) ;
Carrillo-Lopez, Andres (Hospital Universitari Son Espases) ;
Zamora, Alberto (Hospital Comarcal de Blanes) ;
Vega-Hernandez, Berta (Hospital Universitario de Cabueñes) ;
Alameda Serrano, Javier (Hospital Clínico Universitario Lozano Blesa) ;
Rubert, Catalina (Hospital Son Llàtzer) ;
Ruiz-Valdepeñas, Luis (Hospital General Universitario de Ciudad Real) ;
Quintas, Laura (Hospital de Mendaro) ;
Rodríguez-Padial, Luis (Complejo Hospitalario de Toledo) ;
Vaquero, Jessica (Hospital Universitario Araba sede Txagorritxu) ;
Martinez Dolz, Luis (Hospital Universitario La Fe) ;
Barrabes, Jose A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sanchez, Pedro L (Hospital Universitario Salamanca) ;
Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ;
Martí-Almor, Julio (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Elosua, Roberto (Universitat de Vic) ;
Lidon, Rosa-María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Marrugat, Jaume (CIBER Enfermedades Cardiovasculares (CIBERCV)) ;
Universitat Autònoma de Barcelona
Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI ≥75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. [...]
2020 -  10.1136/openhrt-2019-001169
Open Heart, Vol. 7 (august 2020)
|
|
|
2.
|
|
33 p, 1.7 MB |
Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials
/
Ibanez, Borja (Cardiology Department, IIS Fundación Jiménez Díaz Hospital, Madrid, Spain) ;
Aletras, Anthony H. (Lund University, Department of Clinical Sciences Lund, Clinical Physiology, Skane University Hospital, Lund, Sweden) ;
Arai, Andrew E. (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland) ;
Arheden, Hakan (Lund University, Department of Clinical Sciences Lund, Clinical Physiology, Skane University Hospital, Lund, Sweden) ;
Bax, Jeroen (Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, the Netherlands) ;
Berry, Colin (British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, and Golden Jubilee National Hospital, Clydebank, United Kingdom) ;
Bucciarelli-Ducci, Chiara (Bristol Heart Institute, Bristol NIHR Cardiovascular Research Centre, University of Bristol and University Hospitals Bristol NHS Trust, Bristol, United Kingdom) ;
Croisille, Pierre (University Lyon, UJM-Saint-Etienne, INSA, CNRS UMR 5520, INSERM U1206, CREATIS, F-42023, Saint-Etienne, France) ;
Dall'Armellina, Erica (Leeds Institute of Cardiovascular and Metabolic Medicine, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, United Kingdom) ;
Dharmakumar, Rohan (Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, and Division of Cardiology, Department of Medicine, University of California, Los Angeles, California) ;
Eitel, Ingo (University Heart Center Lübeck, Medical Clinic II (Cardiology/ Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck, Germany) ;
Fernández-Jiménez, Rodrigo (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ;
Friedrich, Matthias G. (Department of Medicine, Heidelberg University, Heidelberg, Germany) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca ) ;
Hausenloy, Derek J. (Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA, Nuevo Leon, Mexico) ;
Kim, Raymond J. (Duke Cardiovascular Magnetic Resonance Center, Division of Cardiology, and Department of Radiology, Duke University Medical Center, Durham, North Carolina) ;
Kozerke, Sebastian (Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland) ;
Kramer, Christopher M. (Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, Virginia) ;
Salerno, Michael (Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, Virginia; and) ;
Sánchez-González, Javier (Philips Healthcare, Madrid, Spain) ;
Sanz, Javier (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ;
Fuster, Valentin (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ;
Universitat Autònoma de Barcelona
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema, inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and ultimately replacement by fibrosis). [...]
2019 - 10.1016/j.jacc.2019.05.024
Journal of the American College of Cardiology, Vol. 74 (july 2019) , p. 238-256
|
|
|
3.
|
|
11 p, 1.5 MB |
CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform) : A multicenter preclinical network for testing reproducibility in cardiovascular interventions
/
Rossello, X. (Centro Nacional de Investigaciones Cardiovasculares (CNIC)) ;
Rodriguez-Sinovas, A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vilahur, G. (Institut d'Investigació Biomèdica Sant Pau) ;
Crisóstomo, V. (Centro de Cirugía de Mínima Invasión Jesús Usón) ;
Jorge, I. (Centro Nacional de Investigaciones Cardiovasculares (CNIC)) ;
Zaragoza, C. (Universidad Francisco de Vitoria) ;
Zamorano, J.L. (Servicio de Cardiologia. Hospital Universitario Ramón y Cajal. Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS) ;
Bermejo, J. (Department of Cardiology. Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón and Facultad de Medicina. Universidad Complutense de Madrid) ;
Ordoñez, A. (Instituto de Biomedicina de Sevilla) ;
Boscá, L. (Instituto de Investigaciones Biomédicas Alberto Sols (Centro Mixto CSIC-UAM)) ;
Vázquez, J. (Centro Nacional de Investigaciones Cardiovasculares (CNIC)) ;
Badimón, L. (Institut d'Investigació Biomèdica Sant Pau) ;
Sánchez-Margallo, F.M. (Centro de Cirugía de Mínima Invasión Jesús Usón) ;
Fernández-Avilés, F. (Department of Cardiology. Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón and Facultad de Medicina. Universidad Complutense de Madrid) ;
Garcia-Dorado, D. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ibanez, B. (Cardiology Department. IIS-Fundación Jiménez Díaz Hospital) ;
Universitat Autònoma de Barcelona
Despite many cardioprotective interventions have shown to protect the heart against ischemia/reperfusion injury in the experimental setting, only few of them have succeeded in translating their findings into positive proof-of-concept clinical trials. [...]
2019 - 10.1038/s41598-019-56613-6
Scientific reports (Nature Publishing Group), Vol. 9 Núm. 1 (january 2019) , p. 20290
|
|
|
4.
|
|
10 p, 653.5 KB |
Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome : A population-based cohort study in Catalonia (Spain)
/
Ribera, A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ferreira-Gonzalez, I. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Marsal, J.R. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Oristrell, G. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Faixedas, M.T. (Servei Català de la Salut. Generalitat de Catalunya) ;
Rosas, A. (Generalitat de Catalunya. Departament de Salut) ;
Tizón-Marcos, H. (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Rojas, S. (Cardiology Department. Hospital Universitari de Tarragona Joan XXIII. IISPV. Universidad Rovira Virgili) ;
Labata, C. (Cardiology Department. Hospital Germans Trias i Pujol) ;
Cardenas, M. (Hospital Universitari de Girona Doctor Josep Trueta) ;
Homs, S. (Cardiology Department. Hospital Mútua de Terrassa) ;
Tomas-Querol, C. (Cardiology Department. Hospital Arnau de Vilanova) ;
Garcia-Picart, J. (Institut d'Investigació Biomèdica Sant Pau) ;
Gomez-Hospital, J.A. (Cardiology Department. Hospital de Bellvitge) ;
Pijoan, J.I. (Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica CIBERESP. Spanish Health Institute (ISCIII)) ;
Masotti, M. (Institut Clínic Cardio Vascular (ICCV). Hospital Clínic de Barcelona) ;
Mauri, J. (Cardiology Department. Hospital Germans Trias i Pujol) ;
Garcia Dorado, D. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Objectives Guidelines recommending 12-month dual antiplatelet therapy (DAPT) in patients with ST-elevation acute coronary syndrome (STEACS) undergoing percutaneous coronary intervention (PCI) were published in year 2012. [...]
2019 - 10.1136/bmjopen-2018-028114
BMJ open, Vol. 9 Núm. 7 (2019) , p. e028114
|
|
|
5.
|
|
|
Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease : Baseline results of the PRECISED study
/
Simó, R. (CIBERDEM. ISCIII) ;
Bañeras, J. (CIBER CV. ISCIII) ;
Hernández Pascual, Cristina (CIBERDEM. ISCIII) ;
Rodríguez-Palomares, J. (CIBER CV. ISCIII) ;
Valente, F. (CIBER CV. ISCIII) ;
Gutierrez, L. (CIBER CV. ISCIII) ;
González-Alujas, Teresa. (CIBER CV. ISCIII) ;
Ferreira, I. (CIBER CV. ISCIII) ;
Aguadé-Bruix, S. (Medical and Metabolic Research Area. Nuclear Medicine. Vall d'Hebron Research Institute. Vall d'Hebron Hospital. Autonomous University of Barcelona) ;
Montaner, J. (Neurovascular Research Laboratory. Vall d'Hebron Research Institute. Vall d'Hebron Hospital. Autonomous University of Barcelona) ;
Seron, D. (REDinREN. ISCIII) ;
Genescà, J. (CIBEREHD. ISCIII) ;
Boixadera, A. (Ophthalmology Department. Vall d'Hebron Research Institute. Vall d'Hebron Hospital. Autonomous University of Barcelona) ;
García-Arumí, J. (Ophthalmology Department. Vall d'Hebron Research Institute. Vall d'Hebron Hospital. Autonomous University of Barcelona) ;
Planas, A. (Diabetes and Metabolism Research Unit. Endocrinology Department. Vall d'Hebron Research Unit. Vall d'Hebron Hospital. Autonomous University of Barcelona) ;
Simó-Servat, O. (CIBERDEM. ISCIII) ;
García-Dorado, D. (CIBER CV. ISCIII)
Objective Detection of subclinical cardiovascular disease (CVD) has significant impact on the management of type 2 diabetes. We examined whether the assessment of diabetic retinopathy (DR) is useful for identifying patients at a higher risk of having silent CVD. [...]
2019 - 10.1136/bmjdrc-2019-000845
BMJ open diabetes research and care, Vol. 7 Núm. 1 (29 2019) , p. e000845
|
|
|
6.
|
|
16 p, 4.3 MB |
Ischemic postconditioning reduces reperfusion arrhythmias by adenosine receptors and protein kinase C activation but is independent of KATP channels or connexin 43
/
Diez, E.R. (Institute of Medical and Experimental Biology of Cuyo. CONICET) ;
Sánchez, J.A. (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Prado, N.J. (Institute of Medical and Experimental Biology of Cuyo. CONICET) ;
Zumino, A.Z.P. (Institute of Medical and Experimental Biology of Cuyo. CONICET) ;
García-Dorado, D. (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Miatello, R.M. (Institute of Medical and Experimental Biology of Cuyo. CONICET) ;
Rodríguez-Sinovas, A. (Centro de Investigación Biomédica en Red sobre Enfermedades Cardiovasculares (CIBERCV))
Ischemic postconditioning (IPoC) reduces reperfusion arrhythmias but the antiarrhythmic mechanisms remain unknown. The aim of this study was to analyze IPoC electrophysiological effects and the role played by adenosine A, A and A receptors, protein kinase C, ATP-dependent potassium (K) channels, and connexin 43. [...]
2019 - 10.3390/ijms20235927
International journal of molecular sciences, Vol. 20 Núm. 23 (january 2019) , p. 5927
|
|
|
7.
|
|
6 p, 617.5 KB |
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction : rationale and design of the trial
/
Mathur, Anthony (Queen Mary University of London (UK)) ;
Arnold, Roman (Hospital Clínico Universitario de Valladolid) ;
Assmus, Birgit (Johann-Wolfgang-Goethe University (Germany)) ;
Bartunek, Jozef (VZW Cardiovascular Research Center Aalst (Belgium)) ;
Belmans, Ann (KU Leuven-University of Leuven & Universiteit Hasselt (Belgium)) ;
Bönig, Halvard (Johann-Wolfgang-Goethe University (Germany)) ;
Crea, Filippo (Catholic University of the Sacred Heart (Italy)) ;
Dimmeler, Stefanie (Johann-Wolfgang-Goethe University (Germany)) ;
Dowlut, Sheik (Queen Mary University of London (UK)) ;
Fernández-Avilés, Francisco (Hospital General Universitario Gregorio Marañón) ;
Galiñanes, Manuel (Hospital Universitari Vall d'Hebron) ;
García Dorado, David (Hospital Universitari Vall d'Hebron) ;
Hartikainen, Juha (Kuopio University Hospital and University of Eastern Finland (Finland)) ;
Hill, Jonathan (King's College Hospital (UK)) ;
Hogardt-Noll, Annette (t2cure (Germany)) ;
Homsy, Christian (Celyad SA (Belgium)) ;
Janssens, Stefan (University Hospitals Leuven (Belgium)) ;
Kala, Petr (Faculty Hospital and Masaryk University (Czech Republic)) ;
Kastrup, Jens (Rigshospitalet University of Copenhagen (Denmark)) ;
Martin, John (University College London (UK)) ;
Menasche, Philippe (University Paris Descartes. Assistance Publique Hopitaux de Paris (France)) ;
Miklik, Roman (Faculty Hospital and Masaryk University (Czech Republic)) ;
Mozid, Abdul (Barts Heart Centre (UK)) ;
San Román, J. Alberto (Hospital Clínico Universitario de Valladolid) ;
Sanz-Ruiz, Ricardo (Hospital General Universitario Gregorio Marañón) ;
Tendera, Michal (Medical University of Silesia (Poland)) ;
Wojakowski, Wojtek (Medical University of Silesia (Poland)) ;
Ylä-Herttuala, Seppo (Kuopio University Hospital and University of Eastern Finland (Finland)) ;
Zeiher, Andreas (Johann-Wolfgang-Goethe University (Germany)) ;
Universitat Autònoma de Barcelona
Over the past 13 years bone marrow-derived mononuclear cells () have been widely investigated for clinical efficacy in patients following acute myocardial infarction (). These early phase trials have used various surrogate markers to judge efficacy and, although promising, the results have been inconsistent. [...]
2017 - 10.1002/ejhf.829
European Journal of Heart Failure, Vol. 19, Issue 11 (November 2017) , p. 1545-1550
|
|
|
8.
|
|
15 p, 4.8 MB |
Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease
/
Rodríguez-Palomares, José Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Dux-Santoy, Lydia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Guala, Andrea (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Kale, Raquel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Maldonado, Giuliana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Teixidó-Turà, Gisela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Galian Gay, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Huguet, Marina (Cardiac Imaging Department, CETIR-ERESA, Clínica del Pilar-Sant Jordi, Barcelona, Spain) ;
Valente, Filipa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gutiérrez, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
González-Alujas, Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Johnson, Kevin M. (Madison, WI USA) ;
Wieben, Oliver (Madison, WI USA) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Evangelista, Arturo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
In patients with bicuspid valve (BAV), ascending aorta (AAo) dilatation may be caused by altered flow patterns and wall shear stress (WSS). These differences may explain different aortic dilatation morphotypes. [...]
2018 - 10.1186/s12968-018-0451-1
Journal of Cardiovascular Magnetic Resonance, Vol. 20 (april 2018)
|
|
|
9.
|
|
11 p, 1.0 MB |
Cardiomyocyte hypertrophy induced by Endonuclease G deficiency requires reactive oxygen radicals accumulation and is inhibitable by the micropeptide humanin
/
Blasco, Natividad (Cell Signaling and Apoptosis group, Universitat de Lleida - IRBLleida, Lleida, Spain) ;
Cámara, Yolanda (Research Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona and CIBERER, Barcelona, Spain) ;
Núñez, Estefanía (Cardiovascular Proteomics group, Spanish National Center for Cardiovascular Research (CNIC) and CIBERCV Madrid, Spain) ;
Beà, Aida (Cell Signaling and Apoptosis group, Universitat de Lleida - IRBLleida, Lleida, Spain) ;
Barés, Gisel (Cell Signaling and Apoptosis group, Universitat de Lleida - IRBLleida, Lleida, Spain) ;
Forné, Carles (Universitat de Lleida, Institut de Recerca Biomèdica de Lleida (IRBLleida)) ;
Ruíz-Meana, Marisol (Cardiovascular Diseases Research Group, VHIR and CIBERCV, Barcelona, Spain) ;
Girón, Cristina (Cell Signaling and Apoptosis group, Universitat de Lleida - IRBLleida, Lleida, Spain) ;
Barba, Ignasi (Cardiovascular Diseases Research Group, VHIR and CIBERCV, Barcelona, Spain) ;
García-Arumí, Elena (Research Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona and CIBERER, Barcelona, Spain) ;
García Dorado, David (Cardiovascular Diseases Research Group, VHIR and CIBERCV, Barcelona, Spain) ;
Vázquez, Jesús (Cardiovascular Proteomics group, Spanish National Center for Cardiovascular Research (CNIC) and CIBERCV Madrid, Spain) ;
Martí Seves, Ramon (Research Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona and CIBERER, Barcelona, Spain) ;
Llovera, Marta (Cell Signaling and Apoptosis group, Universitat de Lleida - IRBLleida, Lleida, Spain) ;
Sanchis, Daniel (Cell Signaling and Apoptosis group, Universitat de Lleida - IRBLleida, Lleida, Spain)
The endonuclease G gene (Endog), which codes for a mitochondrial nuclease, was identified as a determinant of cardiac hypertrophy. How ENDOG controls cardiomyocyte growth is still unknown. Thus, we aimed at finding the link between ENDOG activity and cardiomyocyte growth. [...]
2018 - 10.1016/j.redox.2018.02.021
Redox biology, Vol. 16 (march 2018) , p. 146-156
|
|
|
10.
|
|
5 p, 5.1 MB |
Life-threatening and life-saving inappropriate implantable cardioverter defibrillator shocks
/
Pérez Rodon, Jordi (Universitat Autònoma de Barcelona) ;
Doiny, David (Universitat Autònoma de Barcelona) ;
Miranda, Berta (Universitat Autònoma de Barcelona) ;
Rivas Gándara, Nuria (Universitat Autònoma de Barcelona) ;
Roca Luque, Ivo (Universitat Autònoma de Barcelona) ;
Francisco Pascual, Jaume (Universitat Autònoma de Barcelona) ;
Lidón, Rosa Maria (Universitat Autònoma de Barcelona) ;
García Dorado, David (Universitat Autònoma de Barcelona) ;
Moya Mitjans, Àngel (Universitat Autònoma de Barcelona)
An implantable cardioverter defibrillator (ICD) lead dislodgement into the right atrium is a dangerous situation, particularly in patients in atrial fibrillation because atrial fibrillation can be sensed as ventricular fibrillation and true ventricular fibrillation induced with an inappropriate shock. [...]
2017 - 10.1002/ccr3.893
Clinical Case Reports, Vol. 5, Issue 4 (April 2017) , p. 521-525
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
